Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro

International Journal of Cancer

Volumn 65, Issue 4, 1996, Pages 513-518

  Price, Elizabeth A ^a   Coombe, Deirdre R ^b   Murray, J Clifford ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; BREAST ADENOCARCINOMA; CARCINOMA CELL; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

ANIMALS; ANTIGENS, CD44; CELL ADHESION; ENDOTHELIUM, VASCULAR; HUMANS; HYALURONIC ACID; MELANOMA; MICE; TUMOR CELLS, CULTURED;

EID: 0029882218     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960208)65:4<513::AID-IJC20>3.0.CO;2-9     Document Type: Article

References (39)

1. AMANUMA, K. and MITSUI, Y., Hyaluronic acid synthesis is absent in normal human endothelial cells irrespective of hyaluronic acid synthetase inhibitor activity, but is significantly high in transformed cells. Biochem. biophys. Acta, 1092, 336-340 (1991).
2. ARUFFO, A., STAMENKOVIC, I., MELNICK, M., UNDERHILL, C.B. and SEED, B., CD44 is the principal cell surface receptor for hyaluronate. Cell, 61, 1303-1313 (1990).
3. BARTOLAZZI, A., PEACH, R., ARUFFO, A. and STAMENKOVIC, I., Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. exp. Med., 180, 53-66 (1994).
4. BROWN, T.A., BOUCHARD, T., ST. JOHN, T., WAYNER, E. and CARTER, W.G., Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol., 113, 207-221 (1991).
5. BRUVNZEEL, I., KOOPMAN, G., VAN DER RAAIJ, L.M., PALS, S.T. and WILLEMZE, R., CD44 antibody stimulates adhesion of peripheral blood T cells to keratinocytes through the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway. J. invest. Dermatol., 100, 424-428 (1993).
6. CARTER, W.G. and WAYNER, E.A., Characterization of the class II collagen receptor, a phosphorylated, transmembrane alycoprotein expressed in nucleated cells. J. biol. Chem., 263, 4193-4201 (1988).
7. DENNING, S.M., LE, P.T., SINGER, K.H. and HAYNES, B.F., Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T-cell activation. J. Immunol, 144, 7-15 (1990).
8. DOUGHERTY, G.J., COOPER, D.L., MURRAY, J.F. and CHIU, R.K., Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1. J. biol. Chem., 269, 9074-9078 (1994).
9. DROLL, A., DOUGHERTY, S.T., CHUI, R.K., DIRKS, J.F., MCBRIDEL, W.H., COOPER, D.L. and DOUGHERTY, G.J., Adhesive interactions between alternatively spliced CD44 isoforms. J. biol. Chem., 270, 11567-11573 (1995).
10. FAASSEN, A.E., SCHRAGER, J.A.K., D.J., OEGEMA, T.R., COUCHMAN, J.R. and MCCARTHY, J.B., A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type-I collagen-mediated melanoma cell motility and invasion. J. Cell Biol., 116, 521-531 (1992).
11. Fox, S.B., FAWCETT, J., JACKSON, D.G., COLLINS, I., GATTER, K.C., HARRIS, A.L., GEARING, A. and SIMMONS, D.L., Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res . 54, 4539-4546 (1994).
12. GUNTHERT, U., CD44: a multiple of isoforms with diverse functions. Curr. Topics Microbiol. Immunol., 184, 47-63 (1993).
13. GÜNTHERT, U., HOFMANN, M., RUDY, W., REBER, S., ZOLLER, M., HAUSSMANN, I., MATZKU, S., WENZEL, A., PONTA, H. and HERLIRCH, P., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65, 13-24 (1991).
14. Guo, Y., MA, J., CHE, X., NARULA, J., BIGBY, M., WU, M. and SY, M.S., Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res., 54, 1561-1565 (1994).
15. HAYNES, B.F., TELEN, M.J., HALE, L.P. and DENNING, S.M., CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today, 10, 423-428 (1989).
16. HEIDER, K.H., DAMMRICH, J., SKROCH-ANGEL, P., MÜLLER-HERMELINK, H.K., VOLLMERS, H.P., HERRLICH, P. and PONTA, H., Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res., 53, 4197-4203 (1993).
17. HOFMAN, M., RUDY, W., ZÜLLER, M., TOLG, C., PONTA, H., HERRLICH, H. and GÜNTHERT, U., CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res., 51, 5292-5297 (1991).
18. Iozzo, R.V., Proteoglycans: structure, function and role in neoplasia. Lab. Invest., 53, 373-396 (1985).
19. ISHII, S., KIM, J.C., FORD, R., STEELE, T.P. and JESSUP, J.M., CD44 participates in the adhesion of colorectal carcinoma cells to carcinoembryonic antigen. Proc. amer. Ass. Cancer Res., 34, 33 (1993).
20. JAFFE, E.A., NACHMAN, R.L., BECKER, C.G. and MINICK, C.R., Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. clin. Invest., 52, 2745 (1973).
21. JALKANEN, S. and JALKANEN, M., Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol., 116, 817-825 (1992).
22. JALKANEN, S., JALKANEN, M., BARGATZE, R., TAMMI, M. and BUTCHER, E.C., Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol., 141, 1615-1623 (1988).
23. KALOMIRIS, E. and BOURGUIGNON, L.Y.W., Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J. Cell Biol. 106, 319-327 (1988).
24. KOOPMAN, G., VAN KOOYK, Y., DE GRAAFF, M., MEYER, C.J.L.M., FIGDOR, C.G. and PALS, S T., Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J. Immunol., 145, 3589-3593 (1990).
25. LACY, B.E. and UNDERHILL, C.B., The hyaluronate receptor is associated with actin filaments. J. Cell Biol., 105, 1395-1404 (1987).
26. LAURI. D., MARTIN-PADURA, I., BIONDELLI, T., ROSSI, G., BERNASCONI, S., GIAVAZZI, R., PASSERINI, F., VAN HINSBERGH, V. and DEJANA, E., Role of β1 integrins in tumor cell adhesion to cultured human endothelial cells. Lab. Invest., 65, 525-531 (1991).
27. LESLEY, J., HYMAN, R. and KINCADE, P.W., CD44 and its interactions with the extracellular matrix. Adv. Immunol., 54, 271-335 (1993).
28. MCCOLIRT, P.A., EK, B., FORSBERG, N. and GUSTAFSON, S., Intercellular adhesion molecule-1 is a cell surface receptor for hvaluronan. J. biol. Chem., 269, 30081-30084 (1994).
29. PICKER, L.J., DE Los TOYOS, J., HAYNES, B.F. and BLTCHER, E.G., Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J. Immunol., 142, 2046-2051 (1988).
30. PRICE, E.A., COOMBE, D.R. and MURRAY, J.C., A simple fluorometric assay for quantifying the adhesion of tumour cells to endothelial cells. Clin. exp. Meth., 13, 155-164 (1995).
31. SCREATON, G.R., BELL, M.V., JACKSON, D.G., CORNELIS, F.B. and BELL, J.I., Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. nat. Acad. Sci. (Wash.), 89, 12160-12164 (1992).
32. SIMMONS, D.L., WALKER, C., POWER, C. and PIGOTT, R., Molecular cloning of CD31. a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J. exp. Med., 171, 2147-2152 (1990).
33. AMENKOVIC, I., ARUFFO, A., AMIOT, M. and SEED, B., The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J., 10, 343-348 (1991).
34. SY, M.S., Guo, Y.J. and STAMENKOVIC, I., Distinct effects of two CD44 isoforms on tumor growth in vivo. J. exp. Med., 174, 859-866 (1991).
35. 2+-independent adhesion pathway in lymphocyte-endothelial cell interaction. Europ. J. Immunol., 23, 439-446 (1993).
36. TOYAMA-SORIMACHI, N. and MIYASAKA, M., A novel ligand for CD44 is sulphated proteoglycan. Int. Immunol., 6, 655-660 (1994).
37. UNDERHILL, C., CD44: the hyaluronan receptor. J. Cell Sci, 103, 293-298 (1992).
38. WIELENGA, V.J.M., HEIDER, K.H., OFFERHAUS, J.A., ADOLF, G.R., VAN DEN BERG, F.M., PONTA, H., HERRLICH, P. and PALS, S.T., Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53, 4754-4756 (1993).
39. ZHANG, L., UNDERHILL, C.B. and CHEN, L., Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res., 55, 428-433 (1995).